Connor Buffel

The ISMS multidisciplinary team has a proven track record of successful innovative market access assessment and implementation in biotech and pharma. Our MISSION: ISMS aims to ensure patient access to new drug developments by translating intrinsic product value into successful market access. Our TEAM: We are a competent, integrated, multi-disciplinary team, with a solid track record in science, business and marketing. Thanks to our flexible and evolving competencies and skills, we are unrestricted in the type of services and tools we can assist our clients with. We can provide truly integrated, tailor-made support wherever science meets business. Our ADDED VALUE: The ISMS multidisciplinary team has a proven track record of successful innovative market access assessment and implementation in biotech and pharma. We address projects as a multidisciplinary team with a solid track record in science, business, market access and communication, allowing unrestricted flexibility in the type of services and tools we can assist our clients with. Thereby, we can provide truly integrated, tailor-made support to our clients wherever science meets business in a continuously evolving healthcare environment. Our SERVICES: At ISMS we understand e.g. market access strategy optimization, health economic modeling, value communication, health care compliance and also provide ad interim project support. We can therefore cross-fertilize projects: merge insights and learnings, to bring about real added value in an intelligent manner. For more information, please visit our website: www.ismsbelgium.be